Vault-13

Horizon Therapeutics PLC Com

COM · CUSIP 44047T109

0 institutional holders -3 vs Q3 2023
—reported value*
0 new 0 added 0 reduced 3 sold out net sold ≈ $697.1k (-6.0k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q4 2023

Institutional holders

Managers reporting a position, each quarter

0123Q4 22: 1Q1 23: 0Q2 23: 2Q3 23: 3Q4 23: 00Q4 22Q1 23Q2 23Q3 23Q4 23
Numbers
QuarterHolders
Q4 20221
Q1 20230
Q2 20232
Q3 20233
Q4 20230

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
404Q1 23: 0 bought or addedQ1 23: 1 cut or sold outQ1 23Q2 23: 2 bought or addedQ2 23: 0 cut or sold outQ2 23Q3 23: 1 bought or addedQ3 23: 0 cut or sold outQ3 23Q4 23: 0 bought or addedQ4 23: 3 cut or sold outQ4 23
Numbers
QuarterBought or addedCut or sold out
Q1 202301
Q2 202320
Q3 202310
Q4 202303

Biggest buyers

None

Biggest sellers

Bartlett & Co. LLC Sold out -3,000-3.0k
BARTLETT & CO. WEALTH MANAGEMENT LLC Sold out -3,000-3.0k
Byrne Asset Management LLC Sold out -27-27

Holders, Q4 2023

#ManagerLocationShares Value% of their portfolioChangeShares change